Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05007535
Other study ID # SPECTRUM
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date November 10, 2020
Est. completion date February 2, 2023

Study information

Verified date January 2023
Source Erasmus Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This prospective, single arm, observational cohort study is designed to assess the safety and efficacy of (high-definition) intravascular ultrasound (HD-IVUS) as guidance for primary percutaneous coronary intervention (PCI) and to assess culprit lesion plaque characteristics and thrombus morphology in patients with ST-elevation myocardial infarction (STEMI). Objectives: - To assess clinical outcomes after IVUS-guided primary PCI in STEMI patients. - To assess IVUS-guided optimization in STEMI patients. - To assess culprit lesion plaque characteristics in STEMI patients with HD-IVUS. - To assess and quantify thrombus in STEMI patients with HD-IVUS. - To explore HD-IVUS derived predictors for clinically relevant aspiration thrombectomy.


Description:

The SPECTRUM study is an investigator-initiated, single-center, prospective, single arm, observational cohort study investigating the safety and efficacy of (HD)-IVUS as guidance for primary PCI in 200 patients with STEMI. This study enables the assessment of culprit lesion plaque characteristics and thrombus morphology with a 40-60 MHz HD-IVUS catheter. All study patients will have a protocolized pre-intervention IVUS pullback directly after recanalization (so before any lesion preparation, i.e. balloon dilatation, aspiration thrombectomy or stent placement) and a post-intervention IVUS pullback. Subsequently, if IVUS-guided optimization is performed, a final pullback is highly recommended and considered as the post-optimization IVUS pullback. The primary study outcomes are target vessel failure at 12 months and incidence of IVUS-guided optimization. More information on outcome measures is provided in the section below.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 200
Est. completion date February 2, 2023
Est. primary completion date February 2, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Native coronary artery culprit lesion, angiographically - Culprit vessel reference diameter = 2.25 mm, angiographically Exclusion Criteria: - Cardiogenic shock - Presentation > 12 hours after symptom onset

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Netherlands Erasmus University Medical Center Rotterdam

Sponsors (3)

Lead Sponsor Collaborator
Erasmus Medical Center Acist Medical Systems, MicroPort CRM

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Target Vessel Failure (TVF) A composite of cardiac death, target vessel myocardial infarction and clinically driven target vessel revascularization 12 Months
Primary IVUS-guided optimization Incidence of IVUS-guided additional balloon dilatation or stent placement after angiographically successful PCI Procedural
Secondary TVF A composite of cardiac death, target vessel myocardial infarction and clinically driven target vessel revascularization 30 Days
Secondary Major Adverse Cardiovascular Events (MACE) A composite of all-cause mortality, any myocardial infarction and repeat revascularization 30 Days
Secondary Major Adverse Cardiovascular Events (MACE) A composite of all-cause mortality, any myocardial infarction and repeat revascularization 12 Months
Secondary Individual Components of TVF and MACE Individual components of the composite endpoints 30 Days
Secondary Individual Components of TVF and MACE Individual components of the composite endpoints 12 months
Secondary Major Intraprocedural Complications Including type C-F dissections, perforations, slow flow or no-reflow, major side branch occlusion (> 2 mm) Procedural
Secondary Angiographic Endpoints Including final TIMI flow and final myocardial blush grade Procedural
Secondary IVUS endpoints (continuous) At least the following continuous variables will be assessed for the first 100 patients with sufficient HD-IVUS pullbacks:
Minimal lumen area
Thrombus containing frames
Thrombus maximum angle
Minimal stent area
Structured analysis of the HD-IVUS pullbacks will be performed with dedicated invasive imaging analysis software.
Procedural
Secondary IVUS endpoints (categorical) At least the following categorical variables will be assessed for the first 100 patients with sufficient HD-IVUS pullbacks:
Plaque rupture
Convex calcium (nodule)
Thrombus type
Plaque type
Thrombus protrusion
Underexpansion
Edge dissection
Hematoma
High plaque burden at stent edges
Residual focal lesion
Malapposition
Structured analysis of the HD-IVUS pullbacks will be performed with dedicated invasive imaging analysis software.
Procedural
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A